Département de Biochimie Microbiologie et Bioinformatique, Faculté des Sciences et Génie, Université Laval, Québec (Québec), G1K 7P4, Canada.
BMC Microbiol. 2011 Apr 10;11:69. doi: 10.1186/1471-2180-11-69.
The increase in bacterial resistance to antibiotics impels the development of new anti-bacterial substances. Mutacins (bacteriocins) are small antibacterial peptides produced by Streptococcus mutans showing activity against bacterial pathogens. The objective of the study was to produce and characterise additional mutacins in order to find new useful antibacterial substances.
Mutacin F-59.1 was produced in liquid media by S. mutans 59.1 while production of mutacin D-123.1 by S. mutans 123.1 was obtained in semi-solid media. Mutacins were purified by hydrophobic chromatography. The amino acid sequences of the mutacins were obtained by Edman degradation and their molecular mass was determined by mass spectrometry. Mutacin F-59.1 consists of 25 amino acids, containing the YGNGV consensus sequence of pediocin-like bacteriocins with a molecular mass calculated at 2719 Da. Mutacin D-123.1 has an identical molecular mass (2364 Da) with the same first 9 amino acids as mutacin I. Mutacins D-123.1 and F-59.1 have wide activity spectra inhibiting human and food-borne pathogens. The lantibiotic mutacin D-123.1 possesses a broader activity spectrum than mutacin F-59.1 against the bacterial strains tested.
Mutacin F-59.1 is the first pediocin-like bacteriocin identified and characterised that is produced by Streptococcus mutans. Mutacin D-123.1 appears to be identical to mutacin I previously identified in different strains of S. mutans.
细菌对抗生素的耐药性增加促使人们开发新的抗菌物质。Mutacins(细菌素)是由变形链球菌产生的具有抗菌活性的小抗菌肽,针对细菌病原体。本研究的目的是生产和鉴定更多的 Mutacins,以寻找新的有用的抗菌物质。
Mutacin F-59.1 由 S. mutans 59.1 在液体培养基中产生,而 S. mutans 123.1 生产 Mutacin D-123.1 则在半固体培养基中获得。Mutacins 通过疏水层析进行纯化。Mutacins 的氨基酸序列通过 Edman 降解获得,其分子量通过质谱法确定。Mutacin F-59.1 由 25 个氨基酸组成,包含 Ped 肽类细菌素的 YGNGV 共识序列,分子量计算为 2719 Da。Mutacin D-123.1 具有相同的分子量(2364 Da)和相同的前 9 个氨基酸,与 Mutacin I 相同。Mutacins D-123.1 和 F-59.1 对人和食源性病原体具有广泛的活性谱。与测试的细菌菌株相比,类 lantibiotic Mutacin D-123.1 具有更广泛的活性谱。
Mutacin F-59.1 是第一个被鉴定和特征鉴定的由变形链球菌产生的 Ped 肽类细菌素。Mutacin D-123.1 似乎与之前在不同的 S. mutans 菌株中鉴定到的 Mutacin I 相同。